Cargando…

Assessing and monitoring the impact of the national newborn hearing screening program in Israel

BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasser, Janice, Ari-Even Roth, Daphne, Herzberg, Orly, Lerner-Geva, Liat, Rubin, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410489/
https://www.ncbi.nlm.nih.gov/pubmed/30857547
http://dx.doi.org/10.1186/s13584-019-0296-6
_version_ 1783402253314424832
author Wasser, Janice
Ari-Even Roth, Daphne
Herzberg, Orly
Lerner-Geva, Liat
Rubin, Lisa
author_facet Wasser, Janice
Ari-Even Roth, Daphne
Herzberg, Orly
Lerner-Geva, Liat
Rubin, Lisa
author_sort Wasser, Janice
collection PubMed
description BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy spectrum disorders. NHSP targets are diagnosis of hearing impairment by age three months and initiation of habilitation by six months. OBJECTIVES: (1) Review NHSP coverage; (2) Assess NHSP impact on age at diagnosis for hearing impairment and age at initiation of habilitation; (3) Identify contributing factors and barriers to NHSP success. METHODS: (1) Analysis of screening coverage and referral rates for the NHSP; (2) Analysis of demographic data, results of coverage, age at diagnosis and initiation of habilitation for hearing impaired infants pre-implementation and post-implementation of NHSP from 10 habilitation centers; (3) Telephone interviews with parents whose infants failed the screening and were referred for further testing. RESULTS: The NHSP coverage was 98.7% (95.1 to 100%) for approximately 179,000 live births per year for 2014–2016 and average referral rates were under 3%. After three years of program implementation, median age at diagnosis was 3.7 months compared to 9.5 months prior to NHSP. The median age at initiation of habilitation after three years of NHSP was 9.4 months compared to 19.0 prior to NHSP. Parents (84% of 483 sampled) with infants aged 4–6 months participated in the telephone survey. While 84% of parents reported receiving a verbal explanation of the screening results, more than half of the parents reported not receiving written material. Parental report of understanding the test results and a heightened level of concern over the failed screen were associated with timely follow-up. CONCLUSIONS: The findings indicate high screening coverage. The program reduced ages at diagnosis and initiation of habilitation for hearing impaired infants. Further steps needed to streamline the NHSP are improving communication among caregivers to parents to reduce anxiety; increasing efficiency in transferring information between service providers using advanced technology while ensuring continuum of care; reducing wait time for follow-up testing in order to meet program objectives. Establishment of a routine monitoring system is underway.
format Online
Article
Text
id pubmed-6410489
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64104892019-03-21 Assessing and monitoring the impact of the national newborn hearing screening program in Israel Wasser, Janice Ari-Even Roth, Daphne Herzberg, Orly Lerner-Geva, Liat Rubin, Lisa Isr J Health Policy Res Original Research Article BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy spectrum disorders. NHSP targets are diagnosis of hearing impairment by age three months and initiation of habilitation by six months. OBJECTIVES: (1) Review NHSP coverage; (2) Assess NHSP impact on age at diagnosis for hearing impairment and age at initiation of habilitation; (3) Identify contributing factors and barriers to NHSP success. METHODS: (1) Analysis of screening coverage and referral rates for the NHSP; (2) Analysis of demographic data, results of coverage, age at diagnosis and initiation of habilitation for hearing impaired infants pre-implementation and post-implementation of NHSP from 10 habilitation centers; (3) Telephone interviews with parents whose infants failed the screening and were referred for further testing. RESULTS: The NHSP coverage was 98.7% (95.1 to 100%) for approximately 179,000 live births per year for 2014–2016 and average referral rates were under 3%. After three years of program implementation, median age at diagnosis was 3.7 months compared to 9.5 months prior to NHSP. The median age at initiation of habilitation after three years of NHSP was 9.4 months compared to 19.0 prior to NHSP. Parents (84% of 483 sampled) with infants aged 4–6 months participated in the telephone survey. While 84% of parents reported receiving a verbal explanation of the screening results, more than half of the parents reported not receiving written material. Parental report of understanding the test results and a heightened level of concern over the failed screen were associated with timely follow-up. CONCLUSIONS: The findings indicate high screening coverage. The program reduced ages at diagnosis and initiation of habilitation for hearing impaired infants. Further steps needed to streamline the NHSP are improving communication among caregivers to parents to reduce anxiety; increasing efficiency in transferring information between service providers using advanced technology while ensuring continuum of care; reducing wait time for follow-up testing in order to meet program objectives. Establishment of a routine monitoring system is underway. BioMed Central 2019-03-11 /pmc/articles/PMC6410489/ /pubmed/30857547 http://dx.doi.org/10.1186/s13584-019-0296-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Wasser, Janice
Ari-Even Roth, Daphne
Herzberg, Orly
Lerner-Geva, Liat
Rubin, Lisa
Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title_full Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title_fullStr Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title_full_unstemmed Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title_short Assessing and monitoring the impact of the national newborn hearing screening program in Israel
title_sort assessing and monitoring the impact of the national newborn hearing screening program in israel
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410489/
https://www.ncbi.nlm.nih.gov/pubmed/30857547
http://dx.doi.org/10.1186/s13584-019-0296-6
work_keys_str_mv AT wasserjanice assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael
AT arievenrothdaphne assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael
AT herzbergorly assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael
AT lernergevaliat assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael
AT rubinlisa assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael